Ronald C. McGarry, MD, PhD

Clinical interests

  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Skin Cancer
  • Stereotactic Radiotherapy

Ronald C. McGarry, MD, PhD

Biography

Dr. Ronald McGarry discusses the benefits of TomoTherapy.

Ronald C. McGarry, MD, PhD, received his medical degree from the University of Calgary, Alberta, Canada, and is board certified by the American Board of Radiology in radiation oncology.

Faculty rank

Professor of Radiation Medicine

Education

Degree
University of Calgary, Alberta, Canada

Residency
University of Western Ontario Medical School, London, Ontario, Canada

Certifications or Special training
American Board of Radiology, Radiation Oncology

Radiation Medicine

UK Albert B. Chandler Hospital - Pavilion H
Ground Floor
800 Rose St.
Lexington KY 40536-0293

Call 859-323-6486
Call 859-323-6487
Fax 859-257-4931

Amenities
ATM, Dining, Gift shop, Information desk, Post office

Directions to UK Albert B. Chandler Hospital - Pavilion H Parking »



Lung Cancer

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
800 Rose St.
Lexington KY 40536-0098

HBCicon120x123
This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »

Call 859-257-4488
Call 866-340-4488

Directions to Markey Cancer Center »



Musculoskeletal Cancer

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
800 Rose St.
Lexington KY 40536-0098


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Meenach SA, Tsoras AN, McGarry RC, Mansour HM, Hilt JZ, Anderson KW. Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics. Int J Oncol. 2016 Apr;48(4):1701-9.
    View in: PubMed
  2. Jyoti A, Fugit KD, Sethi P, McGarry RC, Anderson BD, Upreti M. An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids. Sci Rep. 2015;5:15236.
    View in: PubMed
  3. McGarry RC. Extensive-Stage Small Cell Lung Cancer: Is Consolidative Thoracic Radiation Therapy Really a New Standard of Care? Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):10-2.
    View in: PubMed
  4. Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies. AAPS PharmSciTech. 2014 Dec;15(6):1574-87.
    View in: PubMed
  5. McGarry RC. Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important? Expert Rev Anticancer Ther. 2014 Dec;14(12):1419-27.
    View in: PubMed
  6. Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Int J Nanomedicine. 2013; 8:275-93. PMID: 23355776.
    View in: PubMed
  7. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol. 2010 Jan; 7(1):44-54. PMID: 19997074.
    View in: PubMed
  8. Forquer JA, Fakiris AJ, McGarry RC, Cheung MK, Watson C, Harkenrider M, Henderson MA, Lo SS. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy. Expert Rev Anticancer Ther. 2009 Oct; 9(10):1443-53. PMID: 19828006.
    View in: PubMed
  9. Henderson MA, Hoopes DJ, Fletcher JW, Lin PF, Tann M, Yiannoutsos CT, Williams MD, Fakiris AJ, McGarry RC, Timmerman RD. A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3):789-95. PMID: 19473777.
    View in: PubMed
  10. Forquer JA, Fakiris AJ, Timmerman RD, Lo SS, Perkins SM, McGarry RC, Johnstone PA. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol. 2009 Dec; 93(3):408-13. PMID: 19454366.
    View in: PubMed
  11. Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, Papiez L, McGarry RC, Wang JZ, Li K, Mayr NA, Timmerman RD. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther. 2009 May; 9(5):621-35. PMID: 19445579.
    View in: PubMed
  12. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009 Nov 1; 75(3):677-82. PMID: 19251380.
    View in: PubMed
  13. Lo SS, Cardenes HR, Teh BS, Fakiris AJ, Henderson MA, Papiez L, McGarry RC, Wang JZ, Li K, Mayr NA, Timmerman RD. Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev Anticancer Ther. 2008 Dec; 8(12):1939-51. PMID: 19046114.
    View in: PubMed
  14. Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol. 2008 Dec 10; 26(35):5755-60. PMID: 19001323.
    View in: PubMed
  15. Henderson M, McGarry R, Yiannoutsos C, Fakiris A, Hoopes D, Williams M, Timmerman R. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008 Oct 1; 72(2):404-9. PMID: 18394819.
    View in: PubMed
  16. Lo SS, Fakiris AJ, Papiez L, Abdulrahman R, McGarry RC, Henderson MA, Forquer JA, Hoopes D, Timmerman RD. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):87-98. PMID: 18095886.
    View in: PubMed
  17. Tinnel B, Mendonca MS, Henderson M, Cummings O, Chin-Sinex H, Timmerman R, McGarry RC. Pulmonary hilar stereotactic body radiation therapy in the rat. Technol Cancer Res Treat. 2007 Oct; 6(5):425-31. PMID: 17877431.
    View in: PubMed
  18. Berk L, Berkey B, Rich T, Hrushesky W, Blask D, Gallagher M, Kudrimoti M, McGarry RC, Suh J, Mehta M. Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys. 2007 Jul 1; 68(3):852-7. PMID: 17418968.
    View in: PubMed
  19. Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, Timmerman RD, McGarry RC. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer. 2007 May; 56(2):229-34. PMID: 17353064.
    View in: PubMed
  20. Sinha B, McGarry RC. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1120-4. PMID: 17145532.
    View in: PubMed
  21. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006 Oct 20; 24(30):4833-9. PMID: 17050868.
    View in: PubMed
  22. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006 Apr; 16(2):77-84. PMID: 16564443.
    View in: PubMed
  23. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1010-5. PMID: 16115740.
    View in: PubMed
  24. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003 Nov; 124(5):1946-55. PMID: 14605072.
    View in: PubMed
  25. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002 Apr; 121(4):1155-8. PMID: 11948046.
    View in: PubMed
  26. Huncharek M, McGarry R, Kupelnick B. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res. 2001 Jan-Feb; 21(1B):765-9. PMID: 11299841.
    View in: PubMed
  27. McGarry RC. Superior vena cava obstruction due to prostate carcinoma. Urology. 2000 Mar; 55(3):436. PMID: 10754173.
    View in: PubMed
  28. McGarry RC, Smith C, Seemayer TA. Treatment resistant small cell carcinoma of the cervix. Oncology. 1999 Nov; 57(4):293-6. PMID: 10575314.
    View in: PubMed